Connect with us

Technology

Scientific Instrument Market size is set to grow by USD 19.96 billion from 2024-2028, Increasing investments in drug discovery boost the market, Technavio

Published

on

NEW YORK, July 31, 2024 /PRNewswire/ — The global scientific instrument market size is estimated to grow by USD 19.96 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 5.45% during the forecast period. Increasing investments in drug discovery is driving market growth, with a trend towards growing adoption of portable scientific instruments. However, lack of trained professionals poses a challenge. Key market players include ABB Ltd., ACMAS Technologies Pvt. Ltd., Agilent Technologies Inc., Alcon Scientific, Bio Rad Laboratories Inc., Bruker Corp., Carl Zeiss AG, Danaher Corp., Hitachi Ltd., HORIBA Ltd., Labappara, M.K.Scientific Instruments, MAC, Merck KGaA, Oxford Instruments plc, Shimadzu Corp., SM Scientific Instruments Pvt. Ltd., Thermo Fisher Scientific Inc., Thorlabs Inc., and Waters Corp..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Scientific Instrument Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.45%

Market growth 2024-2028

USD 19966.9 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

4.77

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 34%

Key countries

US, China, Germany, UK, and India

Key companies profiled

ABB Ltd., ACMAS Technologies Pvt. Ltd., Agilent Technologies Inc., Alcon Scientific, Bio Rad Laboratories Inc., Bruker Corp., Carl Zeiss AG, Danaher Corp., Hitachi Ltd., HORIBA Ltd., Labappara, M.K.Scientific Instruments, MAC, Merck KGaA, Oxford Instruments plc, Shimadzu Corp., SM Scientific Instruments Pvt. Ltd., Thermo Fisher Scientific Inc., Thorlabs Inc., and Waters Corp.

 

Market Driver

The scientific instrument market is experiencing a significant shift towards miniaturized and portable equipment due to the need for space efficiency and convenience in laboratory settings. Vendors are redesigning industry-standard instruments using miniaturization technologies such as fluidics and integrated printed circuit boards (PCBs) to create compact versions of laboratory equipment. Traditional scientific instruments often have complex wiring and components at the bottom and rear, but miniaturization allows for the removal of these elements, making the equipment more compact. Advancements in sensors and wireless connectivity further enable the creation of portable instruments, freeing them from the need for complex wires and cables. Integration of multiple laboratory functions and features onto a single chip through very large-scale integration technologies also saves money, space, and manpower for both vendors and end-users. Miniaturization and nanotechnology have revolutionized point-of-care testing and led to the manufacturing of portable equipment like miniaturized centrifuges from companies such as Bio-Rad Laboratories, Thermo Fisher Scientific, and Merck. These portable analyzers offer quick decision-making capabilities with advanced technologies like X-ray fluorescence (XRF), near-infrared (NIR), Raman, and Fourier transform infrared spectroscopy (FTIR), and an easy-to-use interface. The benefits of miniaturized and portable scientific instruments are driving their demand, and this trend is expected to continue during the forecast period. 

The Scientific Instruments market is thriving, driven by trends in various sectors. Product microscopes, spectrometers, X-ray diffraction, thermal analyzers, and other lab equipment are in high demand. Handheld and portable instruments are popular for field research in healthcare companies, retail sales, and online sales. Biotechnology, materials science, environmental science, private organizations, and academic institutions are major buyers. Electron microscopes, mass spectrometers, DNA sequencers, particle accelerators, and molecular analyzers are key tools for precision medicine, genetic sequencing, drug development, and molecular interactions. Biomarker detection systems, drug safety, and automated solutions are essential for disease mechanisms research in genomics and proteomics. Pharmaceutical companies, analytical instruments manufacturers, startups, and research institutions are investing heavily in this sector. Trends include portable instruments, data analysis, drug safety, and solutions for chronic and target diseases. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

The scientific instrument market is experiencing significant technological advancements at an accelerated pace. Keeping up-to-date with these changes and maintaining a workforce with advanced technical skills is a challenge for end-users due to the high costs of training. Calibration of scientific instruments is crucial for accurate results, yet line inspectors may not possess the necessary technical capabilities. Additionally, interpreting data from these instruments and effectively handling accompanying software requires specialized knowledge. The scarcity of professionals with both medical expertise and software proficiency, coupled with frequent software upgrades and increasing instrument features, poses a critical challenge to the growth of the global scientific instrument market.The Scientific Instrument Market faces several challenges in various sectors. In the healthcare industry, accurate measurement and analysis of urine, tissue, glucose levels, cholesterol levels, and blood cell counts are crucial for medical diagnosis and treatment planning. Infectious diseases, cancer, and chronic conditions like diabetes, respiratory diseases, and cardiovascular diseases require advanced diagnostic tools. Clinical laboratories and hospitals rely on clinical analyzers for quick and accurate results. The biotech and pharmaceutical research sectors need instruments for measuring physical quantities, remodeling, and theoretical research. In the pharmaceutical sectors, verifying the efficacy of therapeutics is essential. Public health emergencies require rapid diagnostic tools for outpatients and inpatients. The research segment focuses on developing instruments for mutated diseases and neurological diseases. Laboratory automation is a key trend to improve efficiency and reduce errors. Overall, meeting the demands of these sectors while ensuring accuracy, reliability, and affordability is a significant challenge for the Scientific Instrument Market.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This scientific instrument market report extensively covers market segmentation by

Product 1.1 Laboratory analytical instruments and consumables1.2 Measuring and monitoring devicesEnd-user 2.1 Pharmaceutical and biotechnology companies2.2 Hospitals and diagnostic laboratories2.3 OthersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Laboratory analytical instruments and consumables- The global scientific instrument market’s laboratory analytical instruments and consumables segment encompasses mass spectrometers, chromatographs, and other tools that assist in diagnosing and analyzing specific infections. These instruments are extensively utilized in life science research, particularly in metabolomics, genomics, and proteomics, employing spectroscopy, mass spectrometry, electrochemical analysis, thermal analysis, separation analysis, and microscopy. The pharmaceutical industry is witnessing a growing demand for Raman spectroscopy to develop new drugs. Raman spectroscopy employs spectrometers and the spectroscopic technique to uncover the chemical structure, concentration, identity, and behavior of molecules in various forms. In pharmaceuticals, Raman spectroscopy is utilized for drug discovery by defining the structural composition of therapeutic drug agents and investigating intermolecular interactions. Post-approval, it ensures the correct compound’s manufacturing and guards against hazardous substances from packaging. Consumables, including funnels, flasks, syringes, and needles, are crucial for drug development and significantly contribute to market expansion due to recurring purchases for diverse testing purposes. Reagents and buffers are among the essential consumables, with their repeated usage in scientific tests and experiments. The variety of reagents required for different testing objectives presents an opportunity for consumables manufacturers to cater to end-users’ diverse needs. Technological advances in reaction buffers have resulted in heightened stability and longevity for reagents and enzymes, driving the growth of the laboratory analytical instruments and consumables segment and the market as a whole.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

The scientific instrument market encompasses a wide range of tools used for measuring, analyzing, verifying, and understanding physical quantities in various sectors. Key product categories include microscopes for observing and examining samples at the microscopic level, spectrometers for identifying and quantifying materials based on their light interaction, X-ray diffraction for determining crystal structures, and thermal analyzers for studying material properties under temperature changes. Handheld and benchtop instruments, as well as portable versions, cater to field research and on-site analysis. Laboratories in pharmaceutical sectors, government, universities, and research institutions utilize these instruments for drug safety, automated solutions, and data analysis. In addition, clinical analyzers are essential in hospitals for public health emergencies and diagnostic purposes. Theoretical research and remodeling also benefit from these tools, ensuring accuracy and advancing scientific knowledge.

Market Research Overview

The scientific instrument market encompasses a wide range of products designed for measuring, analyzing, and verifying physical quantities in various fields. Key product categories include Microscopes (Product and Electron), Spectrometers (Handheld, Benchtop, and Portable), X-ray Diffraction, Thermal Analyzers, and various analyzers like Chromatographs and Particle Analyzers. These instruments find applications in laboratories, healthcare companies, retail and online sales, biotechnology, materials science, environmental science, private organizations, academic institutions, and pharmaceutical companies. Areas of focus include biomarker detection systems, drug development, molecular interactions, biological processes, disease mechanisms, genomics and proteomics, drug discovery, personalized healthcare, and quality control. Additionally, scientific instruments are used in aerospace engineering for cameras, celestial bodies, and planetary exploration, as well as in avionics technology and environmental monitoring. In the healthcare sector, instruments are used for medical diagnosis, treatment planning, infectious diseases, clinical laboratories, and cancer research. In the pharmaceutical sector, instruments play a crucial role in drug safety, automated solutions, data analysis, and pharmaceutical research. The market also includes startups, focusing on areas like drug safety, precision medicine, and automation. Instruments are used in various sectors like chromatographs, particle analyzers, scientific clinical analyzers, and for analyzing biological samples like blood, urine, and tissue. Instruments are used to measure and analyze glucose levels, cholesterol levels, and blood cell counts, among other physical quantities. The market also includes instruments for remodeling, theoretical research, and measuring various physical quantities. In summary, the scientific instrument market caters to a diverse range of applications and industries, enabling advancements in fields like biotechnology, healthcare, pharmaceuticals, and aerospace engineering.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductLaboratory Analytical Instruments And ConsumablesMeasuring And Monitoring DevicesEnd-userPharmaceutical And Biotechnology CompaniesHospitals And Diagnostic LaboratoriesOthersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/scientific-instrument-market-size-is-set-to-grow-by-usd-19-96-billion-from-2024-2028–increasing-investments-in-drug-discovery-boost-the-market-technavio-302210020.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bloomberg Introduces Spread-to-Benchmark Quoting for EUR and GBP Portfolio Trading Baskets

Published

on

By

LONDON, June 2, 2026 /PRNewswire/ — Bloomberg today announced the launch of Spread-to-Benchmark quoting and trading for Euro (EUR) and Sterling (GBP) denominated portfolio trades through its Portfolio Trading Basket Builder (PTBB). The new functionality expands the range of quoting protocols available for European credit portfolio trading and reflects growing client demand for spread-based execution workflows, alongside increased dealer support for the convention across EUR and GBP markets.

Spread-to-Benchmark quoting is a well-established protocol for USD credit portfolio trades and is used by market participants to evaluate and execute portfolio trades. By extending this workflow to EUR and GBP portfolio trades, Bloomberg enables clients and dealers to transact using a familiar spread-based methodology across additional credit markets. 

The introduction of Spread-to-Benchmark quoting for EUR and GBP baskets reflects increased client interest in evaluating portfolio trades through a spread-based lens and the growing adoption of spread-based execution workflows in European credit markets. The workflow provides market participants with an additional framework for assessing the relationship between credit spread risk and underlying government bond yields when pricing and executing portfolio trades. 

Additional Workflow Flexibility 
The workflow complements Bloomberg’s existing portfolio trading capabilities, which support the full range of market-standard quoting conventions, including Price, Yield, Spread-to-Benchmark and Spread based workflows that reference Bloomberg’s evaluated pricing service (BVAL). This gives clients flexibility to compare and execute portfolio trades using the quoting methodology that best aligns with their investment objectives, execution preferences and internal risk management processes. 

“European credit clients continue to look for execution workflows that reflect how they evaluate risk and monitor portfolio trading outcomes,” said Harry Street, Global Head of Credit and Equities Trading Product at Bloomberg. “By expanding dealer support for Spread-to-Benchmark quoting for EUR and GBP baskets, Bloomberg is broadening the range of workflow options available to clients trading European credit portfolios.” 

“Portfolio trading workflows in fixed income continue to become more sophisticated as institutional investors look for ways to evaluate execution quality in changing market conditions,” said Kevin McPartland, Head of Market Structure & Technology Research at Crisil Coalition Greenwich. “Spread-based quoting helps market participants more clearly distinguish between the impacts of credit spread and underlying rates movements when determining how best to execute a portfolio trade.” 

Bloomberg’s Electronic Markets solutions are used by leading financial institutions to trade efficiently in over 175 markets around the world. More than 9,000 client firms use Bloomberg Electronic Markets to access industry-leading depth and breadth of liquidity across asset classes from over 800 dealers globally. Bloomberg Electronic Markets provides market participants with comprehensive solutions across the trading lifecycle, including robust price transparency, analytics, automation and execution, powered by Bloomberg’s high-quality, multi-asset class data and tools.

About Bloomberg
Bloomberg is a global leader in business and financial information, delivering trusted data, news, and insights that bring transparency, efficiency, and fairness to markets. The company helps connect influential communities across the global financial ecosystem via reliable technology solutions that enable our customers to make more informed decisions and foster better collaboration. For more information, visit Bloomberg.com/company or request a demo.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bloomberg-introduces-spread-to-benchmark-quoting-for-eur-and-gbp-portfolio-trading-baskets-302787922.html

SOURCE Bloomberg L.P.

Continue Reading

Technology

Dr. Sunho Kang, a senior battery-technology executive with leadership experience at major global battery and EV manufacturers, joins TeraWatt Technology as Head of Product and Technology

Published

on

By

SAN FRANCISCO, June 2, 2026 /PRNewswire/ — TeraWatt Technology Inc. (Headquartered in California, USA) is pleased to announce that Dr. Sunho Kang has joined the company as Head of Product and Technology.

Dr. Kang is a globally recognized battery-technology executive with more than 25 years of leadership experience spanning the United States, Asia, and Europe, and a distinguished track record of advancing innovations from laboratory research through gigafactory-scale production. He has held senior executive positions at world-leading organizations including Samsung SDI, Apple, and Volkswagen Group of America, and brings deep expertise in lithium-ion battery materials, cell engineering, and product industrialization across a broad range of applications, including electric vehicles and energy storage systems.

At TeraWatt, Dr. Kang will lead global product development and the commercialization of TeraWatt’s battery technology platform, aiming to accelerate the delivery of TeraWatt’s competitive products as well as the technology and commercialization roadmap including manufacturing scale-up.

Dr. Kang commented:

“I am thrilled to join TeraWatt Technology as Head of Product and Technology. TeraWatt’s innovative battery platform presents a tremendous opportunity to push the boundaries of lithium-ion technology, and I look forward to working with the team to accelerate product development and commercialization to deliver meaningful impact.”

TeraWatt Technology founder CEO Ken Ogata, Ph.D. commented:

“We are thrilled to welcome Dr. Kang as our Head of Product and Technology. His deep expertise in battery materials, cell engineering, and productization will be instrumental in accelerating TeraWatt’s product roadmap and technology leadership. Together with Dr. Kang, we will continue to drive our mission forward.”

About TeraWatt Technology Inc.
TeraWatt Technology Inc. is a California-based company that produces lightweight, high-power, and safe next-generation lithium-ion batteries.

Company Overview
Name: TeraWatt Technology Inc.
Representative: Co-founder and CEO Ken Ogata
Headquarters: 28 Geary St, Suite 650, San Francisco, CA 94108, United States
Founded: January 2020
Established: December 2019
URL: https://www.terawatt-technology.com/

 

View original content:https://www.prnewswire.com/news-releases/dr-sunho-kang-a-senior-battery-technology-executive-with-leadership-experience-at-major-global-battery-and-ev-manufacturers-joins-terawatt-technology-as-head-of-product-and-technology-302786854.html

SOURCE TeraWatt Technology Inc.

Continue Reading

Technology

Tencent Cloud and Soniox Announce Strategic Partnership: Combining Advanced Speech-to-Text (STT) Technology with Global Real-Time Infrastructure

Published

on

By

HONG KONG, June 2, 2026 /PRNewswire/ — Tencent Cloud, the cloud business of global technology company Tencent, today announced a strategic partnership with Soniox, a San Francisco-based speech AI company that specializes in developing high-accuracy, low-latency speech AI solutions. The collaboration integrates Soniox’s speech-to-text (STT) technology with Tencent Cloud’s Real-Time Communication (TRTC) enterprise-grade global infrastructure, enabling enterprises to build and deploy multilingual voice AI applications across 200+ countries and regions.

Elevating Enterprise Voice AI at a Global Scale

In enterprise voice AI deployments, latency directly affects user experience and application reliability. The integration of Soniox’s high-accuracy, low-latency STT with TRTC’s global transmission infrastructure reduces latency across the entire pipeline, creating a comprehensive end-to-end solution for enterprises deploying conversational AI applications worldwide.    

Soniox is the voice platform for every language. Unlike legacy speech AI, which was built primarily for English-speakers, Soniox delivers native-speaker accuracy across 60+ languages. Its technology can handle mid-sentence language switching — a user can switch between English and Chinese in a single utterance, and Soniox will capture every word with complete accuracy. All of this works through a single API that works for both speech-to-text and text-to-speech.

By integrating TRTC, the partnership leverages an enterprise-grade real-time communication backbone featuring more than 3,200 global nodes, sub-300 ms worldwide latency, and advanced capabilities such as AI noise suppression and weak-network resilience. These capabilities enable conversational AI applications to operate reliably across diverse network environments, including regions such as Southeast Asia and Africa.

With the roll out of this partnership, developers can integrate the Soniox STT API directly within the Tencent Cloud console. Whether targeting English-speaking markets or supporting languages such as Arabic, Hindi, and Malay, enterprises can build global voice applications — including intelligent customer service, voice assistants, real-time translation, and meeting transcription — to address the demands of expansion into emerging markets and multilingual scenarios.

Wison Xie, Head of Product at Tencent RTC, stated: “Tencent RTC has always been committed to providing reliable real-time communication infrastructure for global enterprises. Our partnership with Soniox brings together our strengths in enterprise-grade audio transmission and Soniox’s advanced speech recognition technology. Together, we are making it easier for businesses to deploy accurate, low-latency voice AI applications across any language and any market.”

Klemen Simonic, CEO at Soniox Inc., stated “At Soniox, our mission is to help businesses understand every word, in any language, with native speaker accuracy and exceptional speed. Partnering with Tencent Cloud combines our speech AI with world-class real-time infrastructure, enabling enterprises to build voice AI experiences that scale globally with low latency and reliability.”

About Tencent Cloud:

Tencent Cloud, one of the world’s leading cloud companies, is committed to creating innovative solutions to resolve real-world issues and enabling digital transformation for smart industries. Through our extensive global infrastructure, Tencent Cloud provides businesses across the globe with stable and secure industry-leading cloud products and services, leveraging technological advancements such as cloud computing, Big Data analytics, AI, IoT, and network security. It is our constant mission to meet the needs of industries across the board, including the fields of gaming, media and entertainment, finance, healthcare, property, retail, travel, and transportation.

About Tencent RTC:

Tencent RTC provides real-time communication solutions, including audio/video calling, live streaming, and in-game voice. With enterprise-grade security, AI-powered enhancements, and a global network of over 3,200 nodes, Tencent RTC powers mission-critical communication for customers worldwide.

About Soniox:

Soniox is a next-generation voice AI company bringing about the end of English-first speech AI. Most people on the planet did not grow up speaking English and often mix languages mid-sentence; and yet legacy speech AI was built for just English. Soniox is different: native-speaker accuracy across 60+ languages, true mid-sentence language switching, and flawless alphanumeric recognition that legacy providers still can’t match. For developers building global apps, Soniox is the only option. Try it for yourself at soniox.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/tencent-cloud-and-soniox-announce-strategic-partnership-combining-advanced-speech-to-text-stt-technology-with-global-real-time-infrastructure-302786832.html

SOURCE Tencent Cloud

Continue Reading

Trending